LOADING
Comparing Eli Lilly and Company (LLY) and JPMorgan Chase (JPM) across the Health Care and Financials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | LLY | JPM |
|---|---|---|
| Price | $935.58 | $294.60 |
| Change Today | -1.98% | -0.26% |
| Market Cap | -- | $794.5B |
| P/E Ratio | -- | 14.7 |
| Forward P/E | -- | 13.8 |
| PEG Ratio | -- | 1.66 |
| EPS | -- | $20.03 |
| Revenue Growth (YoY) | -- | 2.5% |
| Profit Margin | -- | 33.9% |
| Return on Equity | -- | 16.1% |
| Dividend Yield | -- | 1.96% |
| Beta | -- | 1.06 |
| 52-Week High | -- | $335.87 |
| 52-Week Low | -- | $199.32 |
| Volume | 2.7M | 6.7M |